glp-1 incretin Receptor Agonists AdipoGen - Targeting GLP-1, GIP

Definitive answers are eagerly awaited from ongoing trials like the FOCUS study (NCT03811561), which is specifically designed to clarify the long-term impact of semaglutide on diabetic eye disease [96]

For an 8mg dose from this vial concentration, you would need 1.6ml, which exceeds the capacity of a single 1ml syringe, requiring either a larger reconstitution volume or two separate draws

Why the Eyes Matter in GLP-1 Treatment Can GLP-1 Drugs Worsen Diabetic Retinopathy

Sources: White, G

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

Nooms own internal data also shows that the likelihood of experiencing side effects increases significantly as dosages increase